What Pharmaxo Healthcare does

Pharmaxo Healthcare is a UK-based healthcare services company headquartered at 3 Corsham Science Park, operating through two principal subsidiaries: Pharmaxo Compounding, which provides batch and patient-specific pharmaceutical manufacturing under managed-service arrangements, and Pharmaxo Healthcare Clinic, which delivers out-of-hospital care including in-home nursing, clinic-based treatment, and home medication delivery. The company serves NHS healthcare providers as its primary commissioning counterparty, individual patients requiring complex or compounded medicines, and pharmaceutical companies that fund structured patient support programmes. It runs clinical sites in Corsham and Stoke-on-Trent, with an online ordering platform handling prescription intake and medicine dispatch.

The business operates three interlocking revenue streams. First, compounding services are sold to NHS trusts and other healthcare providers on a managed-service basis, combining sterile and non-sterile manufacturing for both batch production and bespoke patient-specific formulations. Second, out-of-hospital care is delivered through professional home-nursing visits, in-clinic treatment, and last-mile medication delivery, monetised via NHS commissioning and private-pay pathways. Third, patient support programmes are structured as recurring, often pharma-funded engagements that wrap adherence, education, and home administration around a sponsor's therapy. Together these create a vertically integrated offering that links formulation, dispensing, clinical delivery, and adherence monitoring.

The company is a subsidiary of Icon Group, a multinational oncology platform with operations in Australia, New Zealand, Singapore, Malaysia, Indonesia, and the UK, which provides patient-flow and capability leverage across borders. Its go-to-market is anchored in long-cycle NHS framework contracts and recurring pharma partnerships, with reputation supported by an award-winning stability programme and two decades of compounding experience. Pricing follows contract-based managed-service and per-patient models rather than transactional or consumption-based structures.

Name

Pharmaxo Healthcare

Legal name

Pharmaxo

Website

https://pharmaxohealthcare.com

Company type

Private

Operating status

Operating

Headcount range

101–250 employees

Short description

Pharmaxo Healthcare is a UK-based healthcare services provider operating pharmaceutical compounding, out-of-hospital nursing, and patient support programmes, primarily serving NHS trusts, complex-medicine patients, and pharmaceutical company partners from Corsham and Stoke-on-Trent under the Icon Group.

Ownership category

akta.pro rank

Product category

Specialty Pharmaceutical Compounding and Out-of-Hospital Care Services

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Offices of Physicians (62111), Pharmacies and Drug Retailers (45611)

SIC

Pharmaceutical Preparations (2834), Services-Skilled Nursing Care Facilities (8051), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Compounding Pharmacies (Sterile/Non-Sterile) (HLAFALAE)

akta.pro secondary industries

Infusion & Home Infusion Pharmacy Services (HLAFALAG), Medication Reconciliation & Transitions-of-Care Pharmacy Services (HLAFALAK), Medication Reconciliation & Skilled Medication Administration (Clinical) (HSABACAH)

Keywords

• Pharmaceutical compounding
• Out-of-hospital care
• Homecare nursing services
• Medication delivery services
• Sterile manufacturing

Headquarters

HQ city

Corsham

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Compounding Services: Provides batch manufacturing and patient-specific compounding services to healthcare providers, NHS, and pharmaceutical companies. Revenue generated through service contracts and product provision.
2. Out-of-Hospital Care Services: Delivers in-home nursing services, clinic services, and medication delivery services. Revenue model based on service delivery contracts with NHS and healthcare providers.
3. Patient Support Programmes: Provides pharmaceutical services and patient support programmes, generating revenue through partnerships with pharmaceutical companies and healthcare systems.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Core offering

Pharmaxo Healthcare delivers pharmaceutical compounding (batch and patient-specific manufacturing of complex medicines with an award-winning extended stability programme) and out-of-hospital care services, including in-home nursing, specialist clinic services, medication delivery, pharmaceutical services, and patient support programmes. It serves NHS healthcare providers, pharmaceutical companies, and patients across the United Kingdom, operating as part of the Icon Group global healthcare network.

Product overview

Pharmaxo Healthcare operates as a unified platform offering pharmaceutical compounding and out-of-hospital care services. The core portfolio consists of two interconnected service areas: Pharmaxo Compounding (Batch Manufacturing, Patient Specific Manufacturing, Extended Stability, Quality Assurance, and the Ordering Platform) and Pharmaxo Healthcare (In-Home Nursing Services, Clinic Services, Medication Delivery Services, Pharmaceutical Services, Patient Support Programmes, and Quality Commitment). These products work together through a Partnership Model that connects NHS healthcare providers, pharmaceutical companies, and patients, enabling seamless treatment pathways from compounding through to homecare delivery.

Differentiator

Problem solved

Functional benefit

Brands

• Pharmaxo Compounding: Specialised compounding capability with advanced stability expertise for complex medicines.
• Pharmaxo Healthcare Clinic

Products and services

• Batch Manufacturing Batch manufacturing service that produces bespoke pharmaceutical compounds in larger quantities for healthcare providers needing reliable supply of complex medicines.
• Patient Specific Manufacturing Patient-specific manufacturing service that creates individualised medications tailored to specific patient needs for healthcare providers and the NHS.
• Extended Stability Programme Award-winning stability programme that extends the usable life of complex medicines, providing healthcare providers with greater flexibility in treatment planning and medicine utilisation.
• In-Home Nursing Services Homecare nursing services supporting treatment delivery beyond the hospital, provided directly to patients in their homes.
• Clinic Services Clinical services delivered in community settings, including the Stoke-on-Trent specialist treatment clinic that brings specialist care closer to patients.
• Medication Delivery Services Services that deliver medications directly to patients, supporting continuity of complex treatment regimens outside hospital settings.
• Pharmaceutical Services Comprehensive pharmaceutical services supporting out-of-hospital care settings, working alongside NHS providers and pharmaceutical companies.
• Patient Support Programmes Support programmes that help patients throughout their treatment journey, delivered in partnership with pharmaceutical companies and NHS providers.

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Icon GroupflagshipOthersPharmaxo Group is part of the Icon Group global network, which operates cancer care centres and pharmacy services across Australia, New Zealand, Singapore, Malaysia, Indonesia, and the United Kingdom. Icon Group is a global oncology platform.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Regional players

• St Andrew's Compounding Services: Specialist compounding pharmacy operating in Australia — sister Icon-adjacent model serving complex-medicine compounding needs; comparable capability but different geography from Pharmaxo.

Direct peers

• Slade Health UK: Sister compounding business under the Icon Group, providing compounded sterile and non-sterile preparations with extended stability expertise — same parent, same core capability as Pharmaxo Compounding.
• HealthNet Homecare: UK specialty homecare company delivering injectable and infused medicines with home nursing services — directly comparable on home infusion, nursing, and medication delivery.
• LloydsPharmacy Clinical Homecare (Hallo Healthcare Group): Large UK clinical homecare and compounding provider delivering home nursing, medication delivery, and bespoke medicines to NHS patients — overlaps directly with Pharmaxo's three service pillars.
• Quantum Pharmaceutical (Ethypharm): UK-based commercial compounding manufacturer producing batch and patient-specific medicines for NHS trusts — closest direct peer to Pharmaxo's batch manufacturing and patient-specific manufacturing lines.
• Sciensus: UK provider of homecare pharmacy services including compounding and home delivery of complex medicines to NHS patients — directly comparable to Pharmaxo on the out-of-hospital care and medication delivery pillars.
• Alcura UK (Phoenix Group): UK homecare pharmacy within the Phoenix/McKesson ecosystem delivering patient support, home nursing, and specialty medicines — comparable on homecare services and pharma patient support programmes.

Broad incumbents

• Boots Pharmacy (Walgreens Boots Alliance): Large UK retail pharmacy chain with dispensing and clinical services — broader incumbent touching patient medication access but not a focused compounding/homecare specialist.
• Bupa Home Healthcare: UK home healthcare arm of Bupa providing home nursing and chronic-condition support — broader incumbent with overlapping out-of-hospital care delivery but no compounding focus.

Others

• Icon Group: Global parent of Pharmaxo operating oncology day hospitals and pharmacy services across multiple countries — adjacent ecosystem participant providing international reach and group-wide compounding standards that shape Pharmaxo's positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@pharmaxogroup
• Facebookfacebook.com/pharmaxohealthcare
• LinkedInlinkedin.com/company/pharmaxo-healthcare
• Xx.com/PharmaxoHealth

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmaxo Healthcare